Vertical Mergers Could Be Challenging for Primary Care

Share this content:
Vertical Mergers Could Be Challenging for Primary Care
Vertical Mergers Could Be Challenging for Primary Care

MONDAY, June 25, 2018 (HealthDay News) -- Vertical level mergers, which incorporate not just health care providers, but also insurers, retailers, and pharmacy benefit managers (PBMs), could pose challenges in primary care, according to an article published in Medical Economics.

In order to compete with other players in health care and new entrants in the industry, the biggest players are merging to increase in size and capability. These mergers could create a new model of primary care, in which much of the care could be given by mid-level providers in retail settings.

Health care mergers are not new, with recent decades witnessing independent practices being absorbed by multi-group practices, which join hospital-based health care systems in horizontal deals. The latest deals do not only involve health care providers, but also insurers, retailers, and PBMs in vertical integrations. Although these mergers may lead to greater efficiencies, lower costs, and better health care, the decisions are mainly being made by profit-oriented chief executive officers; many physicians have expressed skepticism. These mergers make it harder for primary care doctors to remain independent; to retain quasi-independence, they may choose to join an accountable care organization or multi-specialty practice.

Some think the mergers will be good for patients. Payal Bhandari, M.D., a primary care doctor in San Francisco, says that "the primary care model has done a poor job of meeting the needs and preferences of patients and the mergers could fill a gap in care without replacing primary care physicians."

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »